ADU-CRI operates through five specialized research divisions that target critical aspects of cancer care: Genomics and Bioinformatics Research, Biomarker Research, Drug Discovery and Development, Biosensors and Bioengineering, and Public Health Research.
Endocare plans to launch its obesity and metabolic care services in Riyadh within the coming months, building on its successful operations in Dubai and Abu Dhabi.
The upgraded laboratory streamlines sample processing from reception through advanced analysis and genetic sequencing.
Fakeeh University Hospital became the first facility in the region to administer Duvyzat (givinostat), an innovative therapy used to manage Duchenne muscular dystrophy (DMD).
This first-of-its-kind transplantation in Qatar highlights Sidra Medicine’s mission to provide advanced and innovative care for children with complex and high-risk diseases.
NAFDAC’s decision came after assessing outcomes from these surgeries, which used the Toumai system manufactured by Shanghai MicroPort MedBot.
The IAEA’s dosimetry audit is considered one of the most important global verification programmes for radiotherapy centres.
“Nada” functions as a secure digital assistant that allows healthcare professionals to stay fully focused on patients rather than administrative tasks.
The study analysed more than 187,000 laboratory test results from 205 laboratories located in 14 African countries, including Nigeria, using samples collected between 2016 and 2019.
SMA is a rare genetic neuromuscular disease that gradually weakens the muscles needed for movement, swallowing, and breathing, often leading to severe disability if left untreated.